Delivery Order SPE2DR25D1022-SPE2DR26FRD5M
Award Date 5/6/26
Potential Completion Date 5/7/26
Potential Value $8.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $4,715.48 delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for Abraxane 100 mg vials with an ultimate completion date of March 24, 2026. The order is priced on a firm fixed-price basis with no set-aside. Place of performance is Conshohocken, Pennsylvania. The order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical supply vehicle valued at up to $999,999,999 through...
- The Defense Logistics Agency issued a $8,282.60 delivery order to AmerisourceBergen Drug Corp on April 17, 2026, for 100 mg vials of Abraxane (paclitaxel albumin-bound) under firm fixed-price terms, with ultimate completion by April 20, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside designation and is issued against the company's standing pharmaceutical supply agreement with DLA Troop Support Medical, which supports worldwide military healthcare supply across...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $25,931.08 to Amerisourcebergen Drug Corporation for 4561919850 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 24, 2023 under the terms of the contract. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $57,282.72 firm fixed price delivery order contract to supply 4561431450 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 10, 2023 under the terms of this order issued against an existing DLA contract vehicle. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a $78,033 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of ABRAXANE, an injectable chemotherapy drug. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 16-17, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $24,640.84 to Amerisourcebergen Drug Corporation for 4561772767 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen will deliver the chemotherapy drug to its place of performance in Conshohocken, Pennsylvania by August 11, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an...
- The Defense Logistics Agency awarded a delivery order valued at $10,721.90 to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price delivery order includes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery...
- The Defense Logistics Agency awarded a $8,853.94 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Abraxane 100 mg vials, with an ultimate completion date of August 27, 2025. This contract employs firm fixed price terms and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $10,412.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 100 mg vials of ABRAXANE, a chemotherapy medication used to treat breast and lung cancers. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products to DLA and various Department of Defense medical treatment facilities. Amerisourcebergen will fulfill the order from its facility located in Conshohocken,...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 23, 2026, for Abraxane 100 mg vials with a ceiling value of $11,160.61 under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is March 24, 2026. This delivery order carries no set-aside.</p>